-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cerevel Therapeutics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q1 2024.
- Cerevel Therapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 182M shares, a 15.9% increase year-over-year.
- Cerevel Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 162M shares, a 7.13% increase from 2022.
- Cerevel Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 151M shares, a 10.8% increase from 2021.
- Cerevel Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 137M shares, a 85.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)